MKCompany report
McCormick & Company, Incorporated MKC
The bet you're really making is that people keep reaching for the same red-capped McCormick spice tins and French's mustard bottles, and keep paying a few cents more for the name over the store brand beside it. You're betting that even when money is tight, enough shoppers stay loyal that McCormick can raise prices a little every year without losing them to the cheaper jar. Right now it is mixed, with one thing to watch: reported sales look up 16.7% over last year, but almost all of that is McCormick folding in its Mexican partner and a weaker dollar, not more jars sold, and profit per share from continuing operations fell about 11%. You pay about 19 times earnings after stripping out a one-time gain, the least the stock has cost in more than a decade, down from the 30-plus it fetched for most of the 2010s.
Key data
MKC · price with moving averages
Source: market data.
The business
McCormick sells flavor, in two businesses under one roof. The Consumer segment, about two-thirds of the $6.8B in annual sales, is the red-capped spice tins, French's mustard, Frank's RedHot, Cholula, Old Bay and Lawry's that sit in most American kitchens. The Flavor Solutions segment, the other third, sells seasoning blends and flavor formulations to the food manufacturers and restaurant chains whose products you eat without ever seeing McCormick's name. The money is made the way it has been since 1889: a jar of McCormick oregano costs a few cents more than the store brand next to it, and enough shoppers reach for the name anyway that the premium compounds across billions of units. That is the moat, a shelf position and a brand built over 130 years that a private-label supplier cannot simply buy. The tension is that the moat protects price, not volume. Shoppers under pressure switch to the cheaper jar, and McCormick has leaned on price increases to cover flat-to-shrinking units. The red tin still sells. The question is how many, and at whose price.
The numbers
Two things run through the numbers: headline growth that flatters, and earnings that have gone nowhere for four years.
| Quarter | Revenue | Net income (cont.) | Diluted EPS (cont.) |
|---|---|---|---|
| Q2 2025 | $1.66B | $175M | $0.65 |
| Q3 2025 | $1.72B | $226M | $0.84 |
| Q4 2025 | $1.85B | $227M | $0.84 |
| Q1 2026 | $1.87B | $136M | $0.51 |
| Q2 2026 | $1.94B | $157M | $0.58 |
The last quarter looked strong and was not. Reported sales rose 16.7% over a year earlier, but almost all of it came from consolidating McCormick's Mexican joint venture and a softer dollar, not from more jars leaving shelves. Underlying volume stayed the soft spot the earlier read flagged: the open question of whether reported growth was real demand or the Mexico consolidation resolved toward consolidation. Profit told the truth. Operating costs climbed 33% and continuing earnings slipped to $0.58 from $0.65, down about 11% while sales rose 17%. The figures above strip an $886M one-time gain in Q1 that made that quarter's headline EPS meaningless.
| Fiscal year | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2021 | $6.32B | $755M | $2.80 |
| 2022 | $6.35B | $682M | $2.52 |
| 2023 | $6.66B | $681M | $2.52 |
| 2024 | $6.72B | $789M | $2.92 |
| 2025 | $6.84B | $789M | $2.93 |
| 2026, 1H | $3.81B | $293M | $1.09 |
Step back and the picture is a company standing still. Revenue grew about 2% a year over four years, barely ahead of the price increases that drove it, and diluted earnings went from $2.80 to $2.93, essentially flat. Free cash flow is the one bright line, $740M last year against $483M of dividends the cash comfortably covers, and the payout has risen every year for nearly four decades. Buybacks are trivial, about $35M, barely enough to offset stock grants, so the share count hardly moves. Returns look better than the business because of how it is built: return on equity reads 26%, but that is leverage over an equity base carrying more than $11B of goodwill and brands against negative tangible book, and return on invested capital is a duller 6%, below what the debt costs. The variant view is narrow. The market is pricing McCormick as if flat is now permanent, at a multiple it has not carried since the early 2010s. The print that settles it is two straight quarters of positive underlying volume in the Americas.
Management
The record reads capable, not bold. Insiders were net sellers over the last year, about $10.7M, almost all of it a single $10.8M sale by Lawrence Kurzius in August 2026, the kind of diversification a departing executive files rather than a signal on the business. Against it, two open-market purchases totaling roughly $161K, a small vote of confidence. Pay is ordinary for the size: the chief executive took about $10.8M, under 1.4% of profit, weighted toward stock. Capital allocation is where the record disappoints. Management repurchased stock at $74 to $89 in 2022 through 2024 and slowed to a trickle as the price fell to $52, buying high and passing when cheap.
How it fails or surprises you
Volume keeps shrinking. The clearest way to lose. If underlying units stay flat-to-negative and shoppers keep switching to private label, price increases run out of room and the flat-earnings story becomes a declining one. Watch Consumer Americas volume and gross margin together over the next two or three quarters. A second straight quarter of falling volume with softening margin is the tell.
The balance sheet gives no cushion. Net debt sits at 3.35 times EBITDA with $196M of annual interest, high for a staple, and interest is covered only about five and a half times. If EBITDA softens even modestly, coverage tightens, and the room to fund the dividend, the buyback and the debt at once narrows fast. Watch interest expense against operating income.
Volume merely stabilizes (right tail). The upside needs no heroics. A staple that earned 28 to 30 times for most of the last decade sits at 19. If units simply stop shrinking and Frank's RedHot and Flavor Solutions reaccelerate, the multiple re-rates on stability alone. Two consecutive quarters of positive volume is the print that starts it.
Closing thoughts
This is an uncertainty a single print resolves, and the print is underlying volume. The evidence implies a narrow distribution, not a lottery ticket: a stagnant but cash-rich staple the market has marked down to its cheapest in over a decade. The left tail is the one to respect, and it is not a blow-up, it is a value trap, volume eroding another few years while the dividend eats the free cash flow and 3.35-times leverage removes the margin for a stumble. The right tail is a plain re-rating if volume steadies. On the evidence the tails look roughly balanced, the downside slower and the upside larger, which is judgment, not a number.
The bet, in the end, is the same one it started as: people keep reaching for the red-capped McCormick tins and French's bottles and keep paying a few cents more for the name. What breaks it is volume, not price, and the one pair that tells you first is Consumer Americas units against gross margin. If units are still falling two quarters from now, the cheap multiple was cheap for a reason.
Methodology
Sector frame: branded packaged food and flavor ingredients (Consumer Defensive). Anchored to the Form 10-Q for the fiscal quarter ended May 31, 2026 and the fiscal 2025 Form 10-K, with revenue, net income, diluted EPS, debt, goodwill and equity taken as reported. The fiscal year ends in late November, so fiscal quarters do not align to calendar quarters. Quarterly and annual net income and EPS are shown on a continuing-operations basis; the $886M one-time gain booked to discontinued operations in Q1 fiscal 2026 is excluded, and normalized P/E strips it. Reported net sales growth for Q2 fiscal 2026 includes the consolidation of the Mexican joint venture and currency, disclosed by the company as company measures; the volume and pricing split is not restated here. EV/EBITDA, net-debt-to-EBITDA, ROE and ROIC are vendor-computed on trailing figures. Price and range are market data as of Sep 5, 2026. Documentation prepared with AI assistance. Not investment advice.
Fact check: bundle financials reconciled to FMP (revenue, net income, EPS, FCF, dividends, buybacks, ROE, ROIC, debt/EBITDA, interest expense all verified across multiple periods). Forward P/E removed (not verifiable). Segment breakdown, historical P/E context, and Kurzius title not independently verified from primary sources. Final analysis verified as of Sep 6, 2026.
Bid Cap
Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.
Subscribe on Substack


